CRT in Functional MR: Yes, the Prognosis Is Poor in Nonresponders, but Is This a Valid Upfront Therapeutic Option?

Presenter: Matthew Reynolds

REGISTER for free or LOG IN to view this content

CRT in Functional MR: Yes, the Prognosis Is Poor in Nonresponders, but Is This a Valid Upfront Therapeutic Option?

We Recommend